OX40 ligand shuts down IL-10-producing regulatory T cells
暂无分享,去创建一个
M. Gilliet | Tomoki Ito | S. Hanabuchi | F. X. Qin | Yui-Hsi Wang | Omar Duramad | Olivia A. Perng | Yong‐jun Liu
[1] J. Rodríguez-Fernández,et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. , 2006, Blood.
[2] B. Pulendran,et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. , 2006, The Journal of clinical investigation.
[3] T. So,et al. Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] C. Akdis,et al. Regulation of T cells and cytokines by the interleukin‐10 (IL‐10)‐family cytokines IL‐19, IL‐20, IL‐22, IL‐24 andIL‐26 , 2006, European journal of immunology.
[5] M. Ostrowski,et al. Evaluation of OX40 Ligand as a Costimulator of Human Antiviral Memory CD8 T Cell Responses: Comparison with B7.1 and 4-1BBL1 , 2005, The Journal of Immunology.
[6] Yu Wang,et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.
[7] H. Roche,et al. Conjugated Linoleic Acid Suppresses NF-κB Activation and IL-12 Production in Dendritic Cells through ERK-Mediated IL-10 Induction1 , 2005, The Journal of Immunology.
[8] S. Gordon,et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.
[9] C. Hawrylowicz,et al. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.
[10] M. Colombo,et al. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. , 2005, Blood.
[11] M. Roncarolo,et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. , 2005, Blood.
[12] T. Watts,et al. TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.
[13] A. O’Garra,et al. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.
[14] M. Croft,et al. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions , 2004, European journal of immunology.
[15] G. Berry,et al. Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.
[16] S. Mian,et al. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. , 2004, Vaccine.
[17] A. Weinberg,et al. A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions1 , 2004, The Journal of Immunology.
[18] B. Stockinger,et al. IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.
[19] K. Sugamura,et al. Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts. , 2004, Cancer research.
[20] C. Benoist,et al. Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand1 , 2003, The Journal of Immunology.
[21] D. Baltimore,et al. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Mages,et al. ICOS and CD28 reversely regulate IL‐10 on re‐activation of human effector T cells with mature dendritic cells , 2002, European journal of immunology.
[23] G. Berry,et al. Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity , 2002, Nature Medicine.
[24] M. Gilliet,et al. Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells , 2002, The Journal of experimental medicine.
[25] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[26] K. Mills,et al. Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.
[27] K. Sugamura,et al. Critical Involvement of OX40 Ligand Signals in the T Cell Priming Events During Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[28] R. de Waal Malefyt,et al. IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.
[29] S. Ikehara,et al. Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs1 , 2001, The Journal of Immunology.
[30] M. Croft,et al. Development of Allergic Inflammation in a Murine Model of Asthma Is Dependent on the Costimulatory Receptor Ox40 , 2001, The Journal of experimental medicine.
[31] H. Ochs,et al. Induction, binding specificity and function of human ICOS , 2000, European journal of immunology.
[32] A. Enk,et al. Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.
[33] R. Coffman,et al. T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo1 , 2000, The Journal of Immunology.
[34] V. Boussiotis,et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.
[35] T. Aoki,et al. Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis , 2000, The Journal of experimental medicine.
[36] Y. Tanaka,et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. , 1998, Blood.
[37] K. Toellner,et al. CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1 , 1998, The Journal of experimental medicine.
[38] F. Powrie,et al. Interleukin 10 is a growth factor for a population of regulatory T cells , 1998, Gut.
[39] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[40] M. Moser,et al. Effect of interleukin‐10 on dendritic cell maturation and function , 1997, European journal of immunology.
[41] R. de Waal Malefyt,et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.